Table of Contents Author Guidelines Submit a Manuscript
International Journal of Medicinal Chemistry
Volume 2014, Article ID 202784, 31 pages
http://dx.doi.org/10.1155/2014/202784
Review Article

Significance and Biological Importance of Pyrimidine in the Microbial World

1School of Pharmacy, Lloyd Institute of Management & Technology, Plot. No. 11, Knowledge Park II, Greater Noida, Uttar Pradesh 201306, India
2Bioinformatics Centre, Biotech Park, Sector G, Jankipuram, Lucknow, Uttar Pradesh 226021, India
3Gautam Buddh Technical University, IET Campus, Sitapur Road, Lucknow, Uttar Pradesh 226021, India
4Department of Pharmaceutical Sciences, University Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana 136119, India

Received 1 September 2013; Revised 13 January 2014; Accepted 14 January 2014; Published 23 March 2014

Academic Editor: Armando Rossello

Copyright © 2014 Vinita Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Infectious Society of America, Statement of the IDSA Concerning “Bioshield II: Responding to an Diseases Ever-Changing Threat”, IDSA, Alexandria, Va, USA, 2004.
  2. J. S. Bradley, R. Guidos, S. Baragona et al., “Anti-infective research and development-problems, challenges, and solutions,” The Lancet Infectious Diseases, vol. 7, no. 1, pp. 68–78, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. L. Panlilio, D. H. Culver, R. P. Gaynes et al., “Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975–1991,” Infection Control and Hospital Epidemiology, vol. 13, no. 10, pp. 582–586, 1992. View at Google Scholar · View at Scopus
  4. J. Davies, “Origins and evolution of antibiotic resistance,” Microbiologia, vol. 12, no. 1, pp. 9–16, 1996. View at Google Scholar · View at Scopus
  5. A. D. Russell, “Mechanisms of bacterial insusceptibility to biocides,” The American Journal of Infection Control, vol. 29, no. 4, pp. 259–261, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. H. P. Schweizer, “Triclosan: a widely used biocide and its link to antibiotics,” FEMS Microbiology Letters, vol. 202, no. 1, pp. 1–7, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. B. Levy, “Antibiotic and antiseptic resistance: impact on public health,” Pediatric Infectious Disease Journal, vol. 19, no. 10, pp. S120–S122, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. S. B. Levy, “Active efflux, a common mechanism for biocide and antibiotic resistance,” Journal of Applied Microbiology, vol. 92, no. 1, pp. 65S–71S, 2002. View at Publisher · View at Google Scholar
  9. K. Poole, “Mechanisms of bacterial biocide and antibiotic resistance,” Journal of Applied Microbiology, vol. 92, no. 1, pp. 55S–64S, 2002. View at Publisher · View at Google Scholar
  10. M. Hassan, D. van der Lelie, D. Springael, U. Römling, N. Ahmed, and M. Mergeay, “Identification of a gene cluster, CZR, involved in cadmium and zinc resistance in Pseudomonas aeruginosa,” Gene, vol. 238, no. 2, pp. 417–425, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Lerner, “Clinical impact of antibiotic resistance,” Advances in Experimental Medicine and Biology, vol. 456, pp. 7–15, 1998. View at Google Scholar · View at Scopus
  12. D. M. Livermore, “Epidemiology of antibiotic resistance,” Intensive Care Medicine, vol. 26, Supplement 1, pp. S14–S21, 2000. View at Google Scholar · View at Scopus
  13. L. Jeu, F. J. Piacenti, A. G. Lyakhovetskiy, and H. B. Fung, “Voriconazole,” Clinical Therapeutics, vol. 25, no. 5, pp. 1321–1381, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. E. de Clercq, “New developments in anti-HIV chemotherapy,” Il Farmaco, vol. 56, no. 1-2, pp. 3–12, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Poole, “Overcoming antimicrobial resistance by targeting resistance mechanisms,” Journal of Pharmacy and Pharmacology, vol. 53, no. 3, pp. 283–294, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. P. W. Taylor, P. D. Stapleton, and J. P. Luzio, “New ways to treat bacterial infections,” Drug Discovery Today, vol. 7, no. 21, pp. 1086–1091, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. R. M. Coates and Y. Hu, “Novel approaches to developing new antibiotics for bacterial infections,” The British Journal of Pharmacology, vol. 152, no. 8, pp. 1147–1154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. D. W. Kimberlin and R. J. Whitley, “Antiviral resistance: mechanisms, clinical significance, and future implications,” Journal of Antimicrobial Chemotherapy, vol. 37, no. 3, pp. 403–421, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Ju and R. S. Varma, “Aqueous N-heterocyclization of primary amines and hydrazines with dihalides: microwave-assisted syntheses of N-azacycloalkanes, isoindole, pyrazole, pyrazolidine, and phthalazine derivatives,” Journal of Organic Chemistry, vol. 71, no. 1, pp. 135–141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Ju, D. Kumar, and R. S. Varma, “Revisiting nucleophilic substitution reactions: microwave-assisted synthesis of azides, thiocyanates, and sulfones in an aqueous medium,” Journal of Organic Chemistry, vol. 71, no. 17, pp. 6697–6700, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. P. D. Lokhande, B. Y. Waghamare, and S. S. Sakate, “Regioselective one-pot synthesis of 3,5-diarylpyrazoles,” Indian Journal of Chemistry B, vol. 44, no. 11, pp. 2338–2342, 2005. View at Google Scholar · View at Scopus
  22. G. J. Reddy, D. Manjula, K. S. Rao, M. Khalilullah, and D. Latha, “A Direct single step synthesis of 1,3-diaryl-4-cyanopyrazoles and their conversion to 1,3-diaryl-4-(4,6-diamino 1,3,5-triazin-2-yl)pyrazoles,” Indian Journal of Chemistry B, vol. 44, pp. 2412–2415, 2005. View at Google Scholar
  23. C. A. Zificsak and D. J. Hlasta, “Current methods for the synthesis of 2-substituted azoles,” Tetrahedron, vol. 60, no. 41, pp. 8991–9016, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Haino, M. Tanaka, K. Ideta, K. Kubo, A. Mori, and Y. Fukazawa, “Solid-phase synthesis of liquid crystalline isoxazole library,” Tetrahedron Letters, vol. 45, no. 11, pp. 2277–2279, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. García-Valverde and T. Torroba, “Special issue: sulfur-nitrogen heterocycles,” Molecules, vol. 10, no. 2, pp. 318–320, 2005. View at Google Scholar · View at Scopus
  26. D. W. Hopper, A. L. Crombie, J. J. Clemens, and S. Kwon, “Six-membered ring systems: pyridine and benzo derivatives,” Progress in Heterocyclic Chemistry, vol. 21, pp. 330–374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Manlove and M. P. Groziak, “Six-membered ring systems: diazines and benzo derivatives,” Progress in Heterocyclic Chemistry, vol. 21, pp. 375–414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. D. J. Brown, Comprehensive Heterocyclic Chemistry, vol. 14, Pergamon Press, Oxford, UK, 1984, edited by A. R. Katritzky and C. W. Rees.
  29. R. C. Elderfield, Heterocyclic Compounds, vol. 6, John Wiley & Sons, New York, NY, USA, 1957.
  30. P. Y. Bruice, Organic Chemistry, Pearson Education, Singapore, 3rd edition, 2007.
  31. A. E. A. Porter, Diazines and Benzodiazines, vol. 14, Pregamon Press, Elsevier Science BV, Amsterdam, The Netherlands, 1979.
  32. C. O. Kappe, “100 years of the biginelli dihydropyrimidine synthesis,” Tetrahedron, vol. 49, no. 32, pp. 6937–6963, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Sharma, N. Rane, and V. K. Gurram, “Synthesis and QSAR studies of pyrimido[4,5-d]pyrimidine-2,5-dione derivatives as potential antimicrobial agents,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 16, pp. 4185–4190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Prakash, V. Bhardwaj, R. Kumar, P. Tyagi, and K. R. Aneja, “Organoiodine (III) mediated synthesis of 3-aryl/hetryl-5,7-dimethyl-1,2,4-triazolo[4,3-a]pyrimidines as antibacterial agents,” European Journal of Medicinal Chemistry, vol. 39, no. 12, pp. 1073–1077, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Botta, M. Artico, S. Massa et al., “Synthesis, antimicrobial and antiviral activities of isotrimethoprim and some related derivatives,” European Journal of Medicinal Chemistry, vol. 27, no. 3, pp. 251–257, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Agarwal, P. Srivastava, S. K. Raghuwanshi et al., “Chloropyrimidines as a new class of antimicrobial agents,” Bioorganic and Medicinal Chemistry, vol. 10, no. 4, pp. 869–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Roth and B. S. Rauckman, “2,4-Diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)-pyrimidines, useful as antimicrobials,” U.S. Patent 4, 587, 341, 1986.
  38. S. Marquais-Bienewald, W. Holzol, A. Preuss, and A. Mehlin, “Use of substituted 2,4-bis (alkylamino) pyrimidines,” U.S. Patent, 0188453 A1, 2006.
  39. S. M. Daluge, P. Skonezny, B. Roth, and B. S. Raukman, “2,4-Diamino-5-(substituted) pyrimidine, useful as antimicrobials,” U.S. Patent 4, 590, 271, 1986.
  40. S. Ito, K. Masuda, S. Kusano et al., “Pyrimidine derivative, process for preparing same and agricultural or horticultural fungicidal composition containing same,” U.S. Patent 4, 988, 704, 1991.
  41. Y. Nakagawa, S. Bobrov, C. R. Semer, T. A. Kucharek, and M. Harmoto, “Fungicidal pyrimidine derivatives,” U.S. Patent 6, 818, 631 B1, 2004.
  42. N. Agarwal, S. K. Raghuwanshi, D. N. Upadhyay, P. K. Shukla, and V. J. Ram, “Suitably functionalised pyrimidines as potential antimycotic agents,” Bioorganic and Medicinal Chemistry Letters, vol. 10, no. 8, pp. 703–706, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. H. S. Basavaraja, G. M. Sreenivasa, and E. Jayachandran, “Synthesis and biological activity of novel pyrimidino imidazolines,” Indian Journal of Heterocyclic Chemistry, vol. 15, p. 69, 2005. View at Google Scholar
  44. V. J. Ram, N. Haque, and P. Y. Guru, “Chemotherapeutic agents XXV: synthesis and leishmanicidal activity of carbazolylpyrimidines,” European Journal of Medicinal Chemistry, vol. 27, no. 8, pp. 851–855, 1992. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Amir, S. A. Javed, and H. Kumar, “Pyrimidine as anti-inflammatory agent: a review,” Indian Journal of Pharmaceutical Sciences, vol. 68, p. 337, 2007. View at Google Scholar
  46. S. M. Sondhi, S. Jain, A. D. Dwivedi, R. Shukla, and R. Raghubir, “Synthesis of condensed pyrimidines and their evaluation for anti-inflammatory and analgesic activities,” Indian Journal of Chemistry B, vol. 47, no. 1, pp. 136–143, 2008. View at Google Scholar · View at Scopus
  47. S. Vega, J. Alonso, J. A. Diaz, and F. Junquera, “Synthesis of 3-substituted-4-phenyl-2-thioxo-1,2,3,4,5,6,7,8-octahydrobenzo[4,5]thieno[2,3-d]pyrimidines,” Journal of Heterocyclic Chemistry, vol. 27, no. 2, pp. 269–273, 1990. View at Google Scholar · View at Scopus
  48. D. R. Hannah and M. F. G. Stevens, “Structural studies on bioactive compounds—part 38.1: reactions of 5-aminoimidazole-4-carboxamide: synthesis of imidazo[1,5-a]quinazoline-3-carboxamides,” Journal of Chemical Research S, no. 7, pp. 398–401, 2003. View at Google Scholar · View at Scopus
  49. K. Rana, B. Kaur, and B. Kumar, “Synthesis and anti-hypertensive activity of some dihydropyrimidines,” Indian Journal of Chemistry B, vol. 43, no. 7, pp. 1553–1557, 2004. View at Google Scholar · View at Scopus
  50. P. A. S. Smith and R. O. Kan, “Cyclization of isothiocyanates as a route to phthalic and homophthalic acid derivatives,” Journal of Organic Chemistry, vol. 29, no. 8, pp. 2261–2265, 1964. View at Google Scholar · View at Scopus
  51. J. Balzarini and C. McGuigan, “Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication,” Journal of Antimicrobial Chemotherapy, vol. 50, no. 1, pp. 5–9, 2002. View at Google Scholar · View at Scopus
  52. R. W. von Borstel, “Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides,” U.S. Patent 6, 344, 447 B2, 2002.
  53. R. Storer, A. Moussa, P. La Colla, and M. Artico, “Oxo-pyrimidine compounds,” U.S. Patent, 0014774 A1, 2005.
  54. H. W. Lee, Y. K. Bok, B. A. Joong et al., “Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione,” European Journal of Medicinal Chemistry, vol. 40, no. 9, pp. 862–874, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. P. F. Juby, T. W. Hudyma, M. Brown, J. M. Essery, and R. A. Partyka, “Antiallergy agents. 1. 1,6-dihydro-6-oxo-2-phenylpyrimidine-5-carboxylic acids and esters,” Journal of Medicinal Chemistry, vol. 22, no. 3, pp. 263–269, 1979. View at Google Scholar · View at Scopus
  56. A. K. Gupta, Sanjay, H. P. Kayath, A. Singh, G. Sharma, and K. C. Mishra, “Anticonvulsant activity of pyrimidine thiols,” Indian Journal of Pharmacology, vol. 26, no. 3, pp. 227–228, 1994. View at Google Scholar · View at Scopus
  57. A. A. Abu-Hashem, M. M. Youssef, and H. A. R. Hussein, “Synthesis, antioxidant, antituomer activities of some new thiazolopyrimidines, pyrrolothiazolopyrimidines and triazolopyrrolothiazolopyrimidines derivatives,” Journal of the Chinese Chemical Society, vol. 58, no. 1, pp. 41–48, 2011. View at Google Scholar · View at Scopus
  58. A. A. Abu-Hashem, M. F. El-Shehry, and F. A. Badria, “Design and synthesis of novel thiophenecarbohydrazide, thienopyrazole and thienopyrimidine derivatives as antioxidant and antitumor agents,” Acta Pharmaceutica, vol. 60, no. 3, pp. 311–323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. S. A. Rahaman, Y. R. Pasad, P. Kumar, and B. Kumar, “Synthesis and anti-histaminic activity of some novel pyrimidines,” Saudi Pharmaceutical Journal, vol. 17, no. 3, pp. 255–258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Nezu, M. Miyazaki, K. Sugiyama, and I. Kajiwara, “Dimethoxypyrimidine as novel herbicides—part 1: synthesis and herbicidal activity of dimethoxyphenoxyphenoxypyrimidines and analogues,” Pesticide Science, vol. 47, pp. 103–113, 1996. View at Google Scholar
  61. J. W. Coe, A. F. J. Fliri, T. Kaneko, and E. R. Larson, “Pyrimidine derivatives enhancing antitumour activity,” U.S. Patent 5, 491, 234, 1996.
  62. G. A. Breault, N. J. Newcombe, and A. P. Thomas, “Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation,” U.S. Patent 6, 969, 714 B2, 2005.
  63. F. Xie, H. Zhao, L. Zhao, L. Lou, and Y. Hu, “Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 1, pp. 275–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. M. A. Kaldrikyan, L. A. Grigoryan, V. A. Geboyan, F. G. Arsenyan, G. M. Stepanyan, and B. T. Garibdzhanyan, “Synthesis and antitumor activity of some disubstituted 5-(3-methyl-4-alkoxybenzyl)pyrimidines,” Pharmaceutical Chemistry Journal, vol. 34, no. 10, pp. 521–524, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. A. L. S. Rodrigues, J. M. Rosa, V. M. Gadotti et al., “Antidepressant-like and antinociceptive-like actions of 4-(4′-chlorophenyl)-6-(4-methylphenyl)-2-hydrazinepyrimidine Mannich base in mice,” Pharmacology Biochemistry and Behavior, vol. 82, no. 1, pp. 156–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Tani, Y. Yamada, T. Oine, T. Ochiai, R. Ishida, and I. Inoue, “Studies on biologically active halogenated compounds. 1. Synthesis and central nervous system depressant activity of 2-(fluoromethyl)-3-aryl-4(3H)-quinazolinone derivatives,” Journal of Medicinal Chemistry, vol. 22, no. 1, pp. 95–99, 1979. View at Google Scholar · View at Scopus
  67. B. Kumar, B. Kaur, J. Kaur, A. Parmar, R. D. Anand, and H. Kumar, “Thermal/microwave assisted synthesis of substituted tetrahydropyrimidines as potent calcium channel blockers,” Indian Journal of Chemistry B, vol. 41, no. 7, pp. 1526–1530, 2002. View at Google Scholar · View at Scopus
  68. K. S. Jain, T. S. Chitre, P. B. Miniyar et al., “Biological and medicinal significance of pyrimidines,” Current Science, vol. 90, no. 6, pp. 793–803, 2006. View at Google Scholar · View at Scopus
  69. G. H. Hitchings, G. B. Elion, H. Vanderwerff, and E. A. Falco, “Pyrimidine derivatives as antagonists of pteroylglutamic acid,” The Journal of Biological Chemistry, vol. 174, no. 2, pp. 765–766, 1948. View at Google Scholar
  70. S. Futterman, “Enzymatic reduction of folic acid and dihydrofolic acid to tetrahydrofolic acid,” The Journal of Biological Chemistry, vol. 228, no. 2, pp. 1031–1038, 1957. View at Google Scholar · View at Scopus
  71. W. C. Werkheiser, “Specific binding of 4-amino folic acid analogues by folic acid reductase,” The Journal of Biological Chemistry, vol. 236, no. 3, pp. 888–893, 1961. View at Google Scholar
  72. I. Kompis and A. Wick, “Synthese von 4-halogensubstituierten analogen von trimethoprim,” Helvetica Chimica Acta, vol. 60, no. 8, pp. 3025–3034, 1977. View at Publisher · View at Google Scholar
  73. S. Hawser, S. Lociuro, and K. Islam, “Dihydrofolate reductase inhibitors as antibacterial agents,” Biochemical Pharmacology, vol. 71, no. 7, pp. 941–948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Schneider, S. Hawser, and K. Islam, “Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 23, pp. 4217–4221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. C. C. Cheng and B. Roth, “6 recent progress in the medicinal chemistry of 2,4-diaminopyrimidines,” Progress in Medicinal Chemistry, vol. 19, pp. 269–331, 1982. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Hughes, L. C. Roberts, and A. J. Coppridge, “Sulfacytine: a new sulfonamide, double blind comparison with sulfisoxazole in acute uncomplicated urinary tract infections,” Journal of Urology, vol. 114, no. 6, pp. 912–914, 1975. View at Google Scholar · View at Scopus
  77. N. J. White, “The treatment of malaria,” The New England Journal of Medicine, vol. 335, no. 11, pp. 800–806, 1996. View at Publisher · View at Google Scholar · View at Scopus
  78. I. Von Zabern, R. Nolte, H. Przyklenk, and W. Vogt, “Effect of different sulfonamides on the human serum complement system,” International Archives of Allergy and Applied Immunology, vol. 76, no. 3, pp. 205–213, 1985. View at Google Scholar · View at Scopus
  79. M. E. Stolar, “Synergistic antibacterial composition,” U.S. Patent 4, 470, 978, 1984.
  80. A. Carr, R. Penny, and D. A. Cooper, “Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients,” AIDS, vol. 7, no. 1, pp. 65–71, 1993. View at Google Scholar · View at Scopus
  81. J. J. Reddick, S. Saha, J. Lee, J. S. Melnick, J. Perkins, and T. P. Begley, “The mechanism of action of bacimethrin, a naturally occurring thiamin antimetabolite,” Bioorganic and Medicinal Chemistry Letters, vol. 11, no. 17, pp. 2245–2248, 2001. View at Publisher · View at Google Scholar · View at Scopus
  82. P. Singh, R. Kumar, and B. K. Sharma, “Quantitative structure-activity relationship study of 5-iodo- and diaryl-analogues of tubercidin: inhibitors of adenosine kinase,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 18, no. 5, pp. 395–402, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. L. P. G. Wakelin and M. J. Waring, Comprehensive Medicinal Chemistry, Drug Compendium, vol. 2, Pergamon Press, Oxford, UK, 1990, edited by P. G. Sammers.
  84. E. de Clercq, “Antiviral drugs in current clinical use,” Journal of Clinical Virology, vol. 30, no. 2, pp. 115–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. H. Mitsuya, K. J. Weinhold, and P. A. Furman, “3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 20, pp. 7096–7100, 1985. View at Google Scholar · View at Scopus
  86. R. van Leeuwen, C. Katlama, V. Kitchen et al., “Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study,” Journal of Infectious Diseases, vol. 171, no. 5, pp. 1166–1171, 1995. View at Google Scholar · View at Scopus
  87. H. Mitsuya, “Anti-HIV nucleosides: past, present and future,” Journal of Immunoassay, vol. 18, no. 3, pp. 285–287, 1997. View at Publisher · View at Google Scholar
  88. P. M. Woster, Foye's Principles of Medicinal Chemistry, Lippincott Williams & Wilkins, Wolters Kluwar Business, Philadelphia, Pa, USA, 6th edition, 2008.
  89. J. Smith and D. Andes, “Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations,” Therapeutic Drug Monitoring, vol. 30, no. 2, pp. 167–172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. B. Chadwick, M. Addy, and D. M. Walker, “Hexetidine mouthrinse in the management of minor aphthous ulceration and as an adjunct to oral hygiene,” The British Dental Journal, vol. 171, no. 3-4, pp. 83–87, 1991. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Butters, J. Ebbs, S. P. Green et al., “Process development of voriconazole: a novel broad-spectrum triazole antifungal agent,” Organic Process Research and Development, vol. 5, no. 1, pp. 28–36, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Gage and D. A. Stopher, “A rapid HPLC assay for voriconazole in human plasma,” Journal of Pharmaceutical and Biomedical Analysis, vol. 17, no. 8, pp. 1449–1453, 1998. View at Publisher · View at Google Scholar
  93. V. K. Kapoor and H. Singh, Medicinal and Pharmaceutical Chemistry, edited by M. K. Jain, Vallabh Prakashan, Delhi, India, 2nd edition, 2005.
  94. N. V. Kolotova, V. O. Koz'minykh, A. V. Dolzhenko et al., “Substituted amides and hydrazides of dicarboxylic acids. Part 9. Pharmacological activity of the products of interaction of 2-aminopyridines and 2-aminopyrimidine with dicarboxylic acid anhydrides,” Pharmaceutical Chemistry Journal, vol. 35, no. 3, pp. 146–150, 2001. View at Publisher · View at Google Scholar · View at Scopus
  95. T. Govindasami, A. Pandey, N. Palanivelu, and A. Pandey, “Synthesis, characterization and antibacterial activity of biologically important vanillin related hydrazone derivatives,” International Journal of Organic Chemistry, vol. 1, pp. 71–77, 2011. View at Publisher · View at Google Scholar
  96. C. Mallikarjunaswamy, D. G. Bhadregowda, and L. Mallesha, “Synthesis and antimicrobial activity of pyrimidine salts with chloranilic and picric acids,” Journal of Chemistry, vol. 2013, Article ID 727182, 5 pages, 2013. View at Publisher · View at Google Scholar
  97. N. Zanatta, S. S. Amaral, J. M. dos Santos et al., “Convergent synthesis and cruzain inhibitory activity of novel 2-(N′-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines,” Bioorganic and Medicinal Chemistry, vol. 16, no. 24, pp. 10236–10243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. A. M. Balan, O. Florea, C. Moldoveanu, G. Zbancioc, D. Iurea, and I. I. Mangalagiu, “Diazinium salts with dihydroxyacetophenone skeleton: syntheses and antimicrobial activity,” European Journal of Medicinal Chemistry, vol. 44, no. 5, pp. 2275–2279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. P. Mondal, S. Jana, and L. K. Kanthal, “Synthesis of novel mercapto-pyrimidine and amino-pyrimidine derivatives of indoline-2-one as potential antioxidant & antibacterial agents,” The Pharma Research, vol. 3, pp. 17–26, 2010. View at Google Scholar
  100. A. Solankee, S. Lad, S. Solankee, and G. Patel, “Chalcones, pyrazolines and aminopyrimidines as antibacterial agents,” Indian Journal of Chemistry B, vol. 48, no. 10, pp. 1442–1446, 2009. View at Google Scholar · View at Scopus
  101. S. Sukhwal and B. L. Verma, “A new route to 2-piperidino-4,6-diarylpyrimidines,” Indian Journal of Heterocyclic Chemistry, vol. 4, no. 1, pp. 67–68, 1994. View at Google Scholar
  102. V. Desai, C. M. Desai, and D. Patel, “2-Amino-4-(4′-chlorophenyl)-6-substituted)-pyrimidines,” Journal of the Institution of Chemists, vol. 11, pp. 104–105, 2005. View at Google Scholar
  103. A. A. F. Wasfy and A. A. Aly, “Simple synthesis of some diphenylsulfapyrimidine acetates from chalcones and their antimicrobial activity,” Chemical Papers, vol. 57, no. 5, pp. 364–368, 2003. View at Google Scholar · View at Scopus
  104. E. S. Devi, E. O. Prakash, and J. T. Rao, “Pyrimidine derivatives part-1,” Journal of the Institution of Chemists, vol. 74, no. 5, pp. 167–168, 2002. View at Google Scholar
  105. D. B. Yadav, K. B. Venkatesh, and S. S. Sangapure, “Synthesis and biological evaluation of 3-aryl-1-(2-benzofuryl)-2-propen-1-one analogues,” Indian Journal of Heterocyclic Chemistry, vol. 19, no. 2, pp. 117–120, 2009. View at Google Scholar · View at Scopus
  106. S. Kothari, R. Vyas, and B. L. Verma, “A facile one pot conversion of 3′,5′-dibromo-4′-hydroxy substituted chalcones to pyrimidine derivatives and their antibacterial and herbicidal activity,” Indian Journal of Heterocyclic Chemistry, vol. 8, no. 4, pp. 285–288, 1999. View at Google Scholar · View at Scopus
  107. V. H. Babu, P. S. Kumar, K. K. Srinivasan, and G. V. Bhat, “Synthesis, antitumor and antibacterial activities of certain substituted pyrimidines bearing benzofuran,” Indian Journal of Pharmaceutical Sciences, vol. 66, no. 5, pp. 647–652, 2004. View at Google Scholar · View at Scopus
  108. T. Y. Pasha, R. H. Udupi, and A. R. Bhat, “Synthesis and antimicrobial screening of some pyrimidine derivatives,” Indian Journal of Heterocyclic Chemistry, vol. 15, no. 2, pp. 149–152, 2005. View at Google Scholar · View at Scopus
  109. S. Chandrasekaran and S. Nagarajan, “Microwave-assisted synthesis and anti-bacterial activity of some 2-amino-6-aryl-4-(2-thienyl)pyrimidines,” Il Farmaco, vol. 60, no. 4, pp. 279–282, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. A. A. Patel and A. G. Mehta, “Synthesis and characterization of some pyrimidine-quinoline clubbed molecules and their microbicidal efficacy,” Journal of Saudi Chemical Society, vol. 14, no. 2, pp. 203–208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. D. B. A. Kumar, G. K. Prakash, M. N. Kumaraswamy, B. P. Nandeshwarappa, B. S. Sherigara, and K. M. Mahadevan, “Microwave assisted facile synthesis of amino pyrimidines bearing benzofuran and investigation of their antimicrobial activity,” Indian Journal of Chemistry B, vol. 45, no. 7, pp. 1699–1703, 2006. View at Google Scholar · View at Scopus
  112. V. Kanagarajan, J. Thanusu, and M. Gopalakrishnan, “A green chemical approach towards the “one-pot” synthesis, spectral characterization and in vitro antibacterial and antifungal activities of morpholino pyrimidines,” Journal of the Korean Chemical Society, vol. 53, no. 6, pp. 731–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. T. A. Naik and K. H. Chikhalia, “Studies on synthesis of pyrimidine derivatives and their pharmacological evaluation,” E-Journal of Chemistry, vol. 4, no. 1, pp. 60–66, 2007. View at Google Scholar · View at Scopus
  114. V. K. Tirlapur, N. Gandhi, R. Basawaraj, and P. Y. Rajendra, “Synthesis, characterization and biological activities of some new pyrimidines and isoxazoles bearing benzofuran moiety,” International Journal of ChemTech Research, vol. 2, no. 3, pp. 1434–1440, 2010. View at Google Scholar · View at Scopus
  115. N. Ingarsal, G. Saravanan, P. Amutha, and S. Nagarajan, “Synthesis, in vitro antibacterial and antifungal evaluations of 2-amino-4-(1-naphthyl)-6-arylpyrimidines,” European Journal of Medicinal Chemistry, vol. 42, no. 4, pp. 517–520, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. B. Ramesh and T. Sumana, “Synthesis and anti-microbial screening of some new pyrimidine derivatives,” International Journal of Pharmaceutical Sciences, vol. 1, no. 2, pp. 320–322, 2009. View at Google Scholar
  117. L. R. Patil, V. S. Ingle, S. P. Bondge, V. E. Bhingolikar, and R. A. Mane, “Synthesis of new pyrimidines bearing paracetamol and imidazolyl moieties,” Indian Journal of Heterocyclic Chemistry, vol. 11, no. 2, pp. 131–134, 2001. View at Google Scholar · View at Scopus
  118. D. H. Patel, K. H. Chikhalia, N. K. Shah, D. P. Patel, P. B. Kaswala, and V. M. Buha, “Design, synthesis and antimicrobial study of some pyrimidine derivatives,” Pharmaceutical Chemistry Journal, vol. 44, no. 2, pp. 94–98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. R. A. Forsch, S. F. Queener, and A. Rosowsky, “Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 7, pp. 1811–1815, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Ali, S. D. Aster, D. W. Graham et al., “Design and synthesis of novel antibacterial agents with inhibitory activity against DNA polymerase III,” Bioorganic and Medicinal Chemistry Letters, vol. 11, no. 16, pp. 2185–2188, 2001. View at Publisher · View at Google Scholar · View at Scopus
  121. G. Menozzi, L. Mosti, P. Fossa, C. Musiu, C. Murgioni, and P. La Colla, “Synthesis and biological evaluation of azole derivatives, analogues of bifonazole, with a phenylisoxazolyl or phenylpyrimidinyl moiety,” Il Farmaco, vol. 56, no. 9, pp. 633–640, 2001. View at Publisher · View at Google Scholar · View at Scopus
  122. E. Nassar, “Synthesis, (in vitro) antitumour and antimicrobial activity of some pyrazoline, pyridine and pyrimidine derivatives linked to indole moiety,” Journal of American Science, vol. 6, no. 8, pp. 338–347, 2010. View at Google Scholar
  123. A. Nagaraj and C. S. Reddy, “Synthesis and biological study of novel bis-chalcones, bis-thiazines and bis-pyrimidines,” Journal of the Iranian Chemical Society, vol. 5, no. 2, pp. 262–267, 2008. View at Google Scholar · View at Scopus
  124. O. A. Fathalla, W. A. Zaghary, H. H. Radwan, S. M. Awad, and M. S. Mohamed, “Synthesis of new 2-thiouracil-5-sulfonamide derivatives with biological activity,” Archives of Pharmacal Research, vol. 25, no. 3, pp. 258–269, 2002. View at Google Scholar · View at Scopus
  125. K. H. Chikhalia, M. J. Patel, and D. B. Vashi, “Design, synthesis and evaluation of novel quinolyl chalcones as antibacterial agents,” Arkivoc, vol. 2008, no. 13, pp. 189–197, 2008. View at Google Scholar · View at Scopus
  126. P. C. Wyss, P. Gerber, P. G. Hartman et al., “Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening,” Journal of Medicinal Chemistry, vol. 46, no. 12, pp. 2304–2312, 2003. View at Publisher · View at Google Scholar · View at Scopus
  127. M. Brands, Y. C. Grande, R. Endermann, R. Gahlmann, J. Krüger, and S. Raddatz, “Pyrimidinone antibiotics—heterocyclic analogues with improved antibacterial spectrum,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 16, pp. 2641–2645, 2003. View at Publisher · View at Google Scholar · View at Scopus
  128. K. Vijayaramalingam, S. Chandrasekaran, and S. Nagarajan, “Synthesis and antibacterial activity of 4-(1-naphthyl)-6-arylpyrimidin-2-(1H)-ones,” Pharmaceutical Chemistry Journal, vol. 41, no. 5, pp. 253–255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. B. Orzeszko, Z. Kazimierczuk, J. K. Maurin et al., “Novel adamantylated pyrimidines and their preliminary biological evaluations,” Il Farmaco, vol. 59, no. 12, pp. 929–937, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. A. H. Moustafa, H. A. Saad, W. S. Shehab, and M. M. El-Mobayed, “Synthesis of some new pyrimidine derivatives of expected antimicrobial activity,” Phosphorus, Sulfur and Silicon and the Related Elements, vol. 183, no. 1, pp. 115–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. M. M. M. Ramiz, W. A. El-Sayed, A. I. El-Tantawy, and A. A. H. Abdel-Rahman, “Antimicrobial activity of new 4,6-disubstituted pyrimidine, pyrazoline, and pyran derivatives,” Archives of Pharmacal Research, vol. 33, no. 5, pp. 647–654, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. P. Černuchová, G. Vo-Thanh, V. Milata, A. Loupy, S. Jantová, and M. Theiszová, “Utilization of 2-ethoxymethylene-3-oxobutanenitrile in the synthesis of heterocycles possessing biological activity,” Tetrahedron, vol. 61, no. 22, pp. 5379–5387, 2005. View at Publisher · View at Google Scholar · View at Scopus
  133. S. L. Mosley, B. A. Bakke, J. M. Sadler et al., “Carbocyclic pyrimidine nucleosides as inhibitors of S-adenosylhomocysteine hydrolase,” Bioorganic and Medicinal Chemistry, vol. 14, no. 23, pp. 7967–7971, 2006. View at Publisher · View at Google Scholar · View at Scopus
  134. J. A. A. Micky, N. M. Saleh, S. M. Mohamed, S. A. Mohamed, and M. M. Salem, “Reaction and antimicrobial activity of 1-arylethylene benzofuranyl ketone derivatives,” Indian Journal of Chemistry B, vol. 45, no. 6, pp. 1579–1583, 2006. View at Google Scholar · View at Scopus
  135. N. B. Patel and Y. S. Gorgamwala, “Antibacterial study of 2-(Pyrazine-2′-carboxamido)-4-(2′-p-aminobenzene-sulfonamido-4′,6′-dimethyl pyrimidine)-6-(arylthiouriedo)-s-triazine derivatives,” Journal of Indian Council of Chemists, vol. 19, no. 2, pp. 17–20, 2002. View at Google Scholar
  136. S. A. Rahaman, Y. R. Prasad, K. P. Kumar, D. Hareesh, and A. P. Rani, “Synthesis and in vitro antibacterial activity of some novel 2-amino-4,6-D derivatives,” Journal of Sciences, Islamic Republic of Iran, vol. 22, no. 1, pp. 27–31, 2011. View at Google Scholar · View at Scopus
  137. S. G. Khanage, S. A. Raju, P. B. Mohite, and R. B. Pandhare, “Synthesis and pharmacological evaluation of some new pyrimidine derivatives containing 1,2,4-triazole,” Advanced Pharmaceutical Bulletin, vol. 2, no. 2, pp. 213–222, 2012. View at Google Scholar
  138. N. Kaur, A. K. Aggarwal, N. Sharma, and B. Choudhary, “Synthesis and in-vitro antimicrobial activity of pyrimidine derivatives,” International Journal of Pharmaceutical Sciences and Drug Research, vol. 4, no. 3, pp. 199–204, 2012. View at Google Scholar
  139. M. M. M. Hussain, K. I. Bhat, B. C. Revanasiddappa, and D. R. Bharthi, “Synthesis and biological evaluation of some novel 2-mercapto pyrimidines,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 5, no. 2, pp. 471–473, 2013. View at Google Scholar
  140. A. A. Aly and S. A. Nassar, “N-[4-(dicyanomethylazo)phenyl]-2-saccharin-2-ylacetamide in the synthesis of pyridazine and pyrimidine derivatives,” Heteroatom Chemistry, vol. 15, no. 1, pp. 2–8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  141. A. Waheed, M. S. Alorainy, A. A. Alghasham, S. A. Khan, and M. Raza, “Synthesis of a new series of substituted pyrimidines and its evaluation for antibacterial and antinociceptive effects,” International Journal of Health Sciences, vol. 2, no. 1, pp. 39–48, 2008. View at Google Scholar
  142. J. M. Parmar and A. R. Parikh, “Synthesis and biological evaluation of some pyrimidinethiones and related heterocycles,” Indian Journal of Heterocyclic Chemistry, vol. 10, no. 3, pp. 205–208, 2001. View at Google Scholar · View at Scopus
  143. N. Y. Khir Eldin, W. A. Gad, Y. M. Ali, and N. R. Mohamed, “The utility of 6-amino-2-thiouracil for synthesis of bioactive sulfur and phosphorus heterocyclic derivatives,” Egyptian Journal of Chemistry, vol. 50, no. 4, pp. 531–540, 2007. View at Google Scholar · View at Scopus
  144. M. N. Purohi, C. Kunal, G. V. Pujar, Y. C. Mayur, and S. M. Shantakumar, “Synthesis and antibacterial activity of 5-(5′-substituted 1,3,4-oxadiazol-2′-YL) dihydropyrimidinone derivatives,” Indian Journal of Heterocyclic Chemistry, vol. 16, no. 4, pp. 349–352, 2007. View at Google Scholar · View at Scopus
  145. A. H. Moustafa, H. A. Morsy, M. G. Assy, and A. Z. Haikal, “Synthesis and antimicrobial activity of some S-β-D-glucosides of 4-mercaptopyrimidine,” Nucleosides, Nucleotides and Nucleic Acids, vol. 28, no. 9, pp. 835–845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. D. N. Upadhyay and V. J. Ram, “Synthesis of pyrimidine and azolopyrimidines as biodynamic agents,” Indian Journal of Chemistry B, vol. 38, no. 2, pp. 173–177, 1999. View at Google Scholar · View at Scopus
  147. O. A. El-Fattah, E. M. H. Abbas, N. A. Mohamed, and S. I. Abd-Elmoez, “Synthesis and evaluation of some tetrahydropyrimidine derivatives as antimicrobial,” Australian Journal of Basic and Applied Sciences, vol. 4, no. 1, pp. 27–36, 2010. View at Google Scholar · View at Scopus
  148. A. H. Moustafa, H. A. Morsy, and A. Z. Haikal, “Synthesis and antimicrobial activity of some S-and-N-β-D-glucosides of pyrimidin-4-thiol,” in Proceedings of the 4th Environmental Conference, pp. 47–63, Faculty of Science, Zigzag University, 2009.
  149. T. Tomašić, N. Zidar, M. Mueller-Premru, D. Kikelj, and L. P. Mašič, “Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones,” European Journal of Medicinal Chemistry, vol. 45, no. 4, pp. 1667–1672, 2010. View at Publisher · View at Google Scholar · View at Scopus
  150. O. A. Fathalla, I. F. Zied, M. E. Haiba et al., “Synthesis, antibacterial and anticancer evaluation of some pyrimidine derivatives,” World Journal of Chemistry, vol. 4, pp. 127–132, 2009. View at Google Scholar
  151. L. C. Heda, R. Sharma, C. Pareek, and P. B. Chaudhari, “Synthesis and antimicrobial activity of some derivatives of 5-substituted indole dihydropyrimidines,” E-Journal of Chemistry, vol. 6, no. 3, pp. 770–774, 2009. View at Google Scholar · View at Scopus
  152. S. Prachayasittikul, N. Sornsongkhram, R. Pingaew, S. Techatanachai, S. Ruchirawat, and V. Prachayasittikul, “Synthesis and novel bioactivities of substituted 6-propylthiouracils,” European Journal of Scientific Research, vol. 36, no. 2, pp. 236–245, 2009. View at Google Scholar · View at Scopus
  153. H. S. Basavaraja, K. V. Jayadevaiah, M. M. Hussain, V. Kumar, and B. Padmashali, “Synthesis of novel piperazine and morpholine linked substituted pyrimidine derivatives as antimicrobial agents,” Journal of Pharmaceutical Sciences and Research, vol. 2, no. 1, pp. 5–12, 2010. View at Google Scholar · View at Scopus
  154. J. D. Akbari, P. K. Kachhadia, S. D. Tala et al., “Synthesis of some new 1,2,3,4-tetrahydropyrimidine-2-thiones and their thiazolo[3,2-α]pyrimidine derivatives as potential biological agents,” Phosphorus, Sulfur and Silicon and the Related Elements, vol. 183, no. 8, pp. 1911–1922, 2008. View at Publisher · View at Google Scholar · View at Scopus
  155. A. A. Bekhit, O. A. El-Sayed, E. Aboulmagd, and J. Y. Park, “Tetrazolo[1,5-a]quinoline as a potential promising new scaffold for the synthesis of novel anti-inflammatory and antibacterial agents,” European Journal of Medicinal Chemistry, vol. 39, no. 3, pp. 249–255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  156. Q. Yan, R. Cao, W. Yi et al., “Inhibitory effects of 5-benzylidene barbiturate derivatives on mushroom tyrosinase and their antibacterial activities,” European Journal of Medicinal Chemistry, vol. 44, no. 10, pp. 4235–4243, 2009. View at Publisher · View at Google Scholar · View at Scopus
  157. S. N. Sriharsha, S. Satish, S. Shashikanth, and K. A. Raveesha, “Design, synthesis and antibacterial activity of novel 1,3-thiazolidine pyrimidine nucleoside analogues,” Bioorganic and Medicinal Chemistry, vol. 14, no. 22, pp. 7476–7481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  158. A. Padmaja, T. Payani, G. D. Reddy, and V. Padmavathi, “Synthesis, antimicrobial and antioxidant activities of substituted pyrazoles, isoxazoles, pyrimidine and thioxopyrimidine derivatives,” European Journal of Medicinal Chemistry, vol. 44, no. 11, pp. 4557–4566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  159. A. R. Gholap, K. S. Toti, F. Shirazi, M. V. Deshpande, and K. V. Srinivasan, “Efficient synthesis of antifungal pyrimidines via palladium catalyzed Suzuki/Sonogashira cross-coupling reaction from Biginelli 3,4-dihydropyrimidin-2(1H)-ones,” Tetrahedron, vol. 64, no. 44, pp. 10214–10223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  160. K. K. Joshi, J. Akbari, and H. S. Joshi, “Evaluations of antimicrobial activity of some pharmacological important dihydropyrimidines compounds,” Journal of Cell and Tissue Research, vol. 10, no. 2, pp. 2243–2250, 2010. View at Google Scholar
  161. P. Sharma, A. Kumar, and M. Sharma, “Synthesis and QSAR studies on 5-[2-(2-methylprop1-enyl)-1H benzimidazol-1yl]-4,6-diphenyl-pyrimidin-2-(5H)-thione derivatives as antibacterial agents,” European Journal of Medicinal Chemistry, vol. 41, no. 7, pp. 833–840, 2006. View at Publisher · View at Google Scholar · View at Scopus
  162. E. Septioǧlu, M. D. Aytemir, E. Kiliç, M. Özalp, and U. Çaliş, “Synthesis of some new N,N-disubstituted dithiocarbamic acid 2-(6-arylhexahydropyrimidine-2,4-dion-3-yl)ethyl esters and in vitro evaluation of antimicrobial activities,” FABAD Journal of Pharmaceutical Sciences, vol. 29, no. 1, pp. 1–6, 2004. View at Google Scholar · View at Scopus
  163. C. Robson, M. A. Meek, J.-D. Grunwaldt et al., “Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents,” Journal of Medicinal Chemistry, vol. 40, no. 19, pp. 3040–3048, 1997. View at Publisher · View at Google Scholar · View at Scopus
  164. D. V. Singh, A. R. Mishra, and R. M. Mishra, “Synthesis and characterization of some antifungal pyrimidinone derivatives,” Indian Journal of Heterocyclic Chemistry, vol. 14, no. 1, pp. 43–46, 2004. View at Google Scholar · View at Scopus
  165. R. Bamnela and S. P. Shrivastava, “Synthesis and in vitro antimicrobial, anthelmintic and insecticidal activities study of 4(4′-bromophenyl)-6-substituted-aryl-1-acetyl pyrimidine-2-thiols,” E-Journal of Chemistry, vol. 7, no. 3, pp. 935–941, 2010. View at Google Scholar · View at Scopus
  166. D. J. Trantolo, G. E. Wright, and N. C. Brown, “Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines,” Journal of Medicinal Chemistry, vol. 29, no. 5, pp. 676–681, 1986. View at Google Scholar · View at Scopus
  167. B. Shivkumar, S. Singh, T. Y. Pasha et al., “Synthesis of certain pyrimidines as antimicrobial agents,” Indian Journal of Heterocyclic Chemistry, vol. 17, no. 2, pp. 197–198, 2007. View at Google Scholar · View at Scopus
  168. B. D. Dhorajiya, M. H. Malani, J. R. Patel, and B. Z. Dholakiya, “Antimicrobial activities of synthesized and characterized 5-acetyl pyrimidine-2,4,6-(1H,3H,5H)-trione based chalcones,” Der Pharma Chemica, vol. 4, no. 1, pp. 141–146, 2012. View at Google Scholar
  169. K. Elumalai, M. A. Ali, M. Elumalai, K. Eluri, and S. Srinivasan, “Novel isoniazid cyclocondensed 1,2,3,4-tetrahydropyrimidine derivatives for treating infectious disease: a synthesis and in vitro biological evaluation,” Journal of Acute Disease, vol. 2, no. 4, pp. 316–321, 2013. View at Publisher · View at Google Scholar
  170. B. Andrews and M. Ahmed, “Synthesis and characterization of pyrimidine bearing 1,3,4-oxadiazole derivatives and their potential antifungal action,” International Journal of Chemical Studies, vol. 1, no. 4, pp. 32–39, 2013. View at Google Scholar
  171. H. Sohn, K.-S. Lee, Y.-K. Ko et al., “In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria,” International Journal of Antimicrobial Agents, vol. 31, no. 6, pp. 567–571, 2008. View at Publisher · View at Google Scholar · View at Scopus
  172. A. Rosowsky, R. A. Forsch, and S. F. Queener, “Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(ω-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim,” Journal of Medicinal Chemistry, vol. 45, no. 1, pp. 233–241, 2002. View at Publisher · View at Google Scholar · View at Scopus
  173. R. C. Reynolds, S. R. Campbell, R. G. Fairchild et al., “Novel boron-containing, nonclassical antifolates: synthesis and preliminary biological and structural evaluation,” Journal of Medicinal Chemistry, vol. 50, no. 14, pp. 3283–3289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  174. A. R. Trivedi, D. K. Dodiya, N. R. Ravat, and V. H. Shah, “Synthesis and biological evaluation of some new pyrimidines via a novel chalcone series,” Arkivoc, vol. 2008, no. 11, pp. 131–141, 2008. View at Google Scholar · View at Scopus
  175. M. L. Read, M. Brændvang, P. O. Miranda, and L. Gundersen, “Synthesis and biological evaluation of pyrimidine analogs of antimycobacterial purines,” Bioorganic and Medicinal Chemistry, vol. 18, no. 11, pp. 3885–3897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  176. K. Umaa, M. Ramanathan, K. Krishnakumar, and K. Kannan, “Elucidation and evaluation of substituted pyrimidines,” Asian Journal of Chemistry, vol. 21, no. 9, pp. 6674–6678, 2009. View at Google Scholar · View at Scopus
  177. A. A. Siddiqui, R. Rajesh, M. Islam, V. Alagarsamy, and E. de Clercq, “Synthesis, antiviral, antituberculostic, and antibacterial activities of some novel, 4-(4-substituted phenyl)-6-(4-nitrophenyl)-2-(substituted imino)pyrimidines,” Archiv der Pharmazie, vol. 340, no. 2, pp. 95–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  178. V. Virsodia, R. R. S. Pissurlenkar, D. Manvar et al., “Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides,” European Journal of Medicinal Chemistry, vol. 43, no. 10, pp. 2103–2115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  179. N. C. Srivastav, T. Manning, D. Y. Kunimoto, and R. Kumar, “Studies on acyclic pyrimidines as inhibitors of mycobacteria,” Bioorganic and Medicinal Chemistry, vol. 15, no. 5, pp. 2045–2053, 2007. View at Publisher · View at Google Scholar · View at Scopus
  180. N. C. Srivastav, D. Rai, C. Tse, B. Agrawal, D. Y. Kunimoto, and R. Kumar, “Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2′-deoxynucleoside analogues using in vitro and in vivo models,” Journal of Medicinal Chemistry, vol. 53, no. 16, pp. 6180–6187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  181. M. Johar, T. Manning, C. Tse et al., “Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-β-D-2′-arabinofuranosyl and 1-(2′-deoxy-2′-fluoro-β-D-2′-ribofuranosyl) pyrimidine nucleoside analogs,” Journal of Medicinal Chemistry, vol. 50, no. 15, pp. 3696–3705, 2007. View at Publisher · View at Google Scholar · View at Scopus
  182. A. Agarwal, K. Srivastava, S. K. Puri, and P. M. S. Chauhan, “Synthesis of 2,4,6-trisubstituted pyrimidines as antimalarial agents,” Bioorganic and Medicinal Chemistry, vol. 13, no. 15, pp. 4645–4650, 2005. View at Publisher · View at Google Scholar · View at Scopus
  183. B. Tarnchompoo, C. Sirichaiwat, W. Phupong et al., “Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine resistant Plasmodium falciparum,” Journal of Medicinal Chemistry, vol. 45, no. 6, pp. 1244–1252, 2002. View at Publisher · View at Google Scholar · View at Scopus
  184. J. M. Coterón, D. Catterick, J. Castro et al., “Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series,” Journal of Medicinal Chemistry, vol. 53, no. 16, pp. 6129–6152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  185. M. A. Dea-Ayuela, E. Castillo, M. Gonzalez-Alvarez et al., “In vivo and in vitro anti-leishmanial activities of 4-nitro-N-pyrimidinand N-pyrazin-2-ylbenzenesulfonamides, and N2-(4-nitrophenyl)-N1propylglycinamide,” Bioorganic and Medicinal Chemistry, vol. 17, no. 21, pp. 7449–7456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  186. L. Gupta, N. Sunduru, A. Verma et al., “Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani,” European Journal of Medicinal Chemistry, vol. 45, no. 6, pp. 2359–2365, 2010. View at Publisher · View at Google Scholar · View at Scopus
  187. S. F. Chowdhury, V. B. Villamor, R. H. Guerrero et al., “Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase,” Journal of Medicinal Chemistry, vol. 42, no. 21, pp. 4300–4312, 1999. View at Publisher · View at Google Scholar · View at Scopus
  188. N. Chandra, R. Ramesh, A. Ashutosh, N. Goyal, S. N. Suryawanshi, and S. Gupta, “Antileishmanial agents part-IV: synthesis and antileishmanial activity of novel terpenyl pyrimidines,” European Journal of Medicinal Chemistry, vol. 40, no. 6, pp. 552–556, 2005. View at Publisher · View at Google Scholar · View at Scopus
  189. H. Parveen, F. Hayat, A. Salahuddin, and A. Azam, “Synthesis, characterization and biological evaluation of novel 6-ferrocenyl-4-aryl-2-substituted pyrimidine derivatives,” European Journal of Medicinal Chemistry, vol. 45, no. 8, pp. 3497–3503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  190. B. K. Singh, M. Mishra, N. Saxena et al., “Synthesis of 2-sulfanyl-6-methyl-1,4-dihydropyrimidines as a new class of antifilarial agents,” European Journal of Medicinal Chemistry, vol. 43, no. 12, pp. 2717–2723, 2008. View at Publisher · View at Google Scholar · View at Scopus
  191. P. Selvam, M. Chandramohan, E. de Clercq, M. Witvrouw, and C. Pannecouque, “Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzene sulfonamide and its derivatives,” European Journal of Pharmaceutical Sciences, vol. 14, no. 4, pp. 313–316, 2001. View at Publisher · View at Google Scholar · View at Scopus
  192. A. Holý, I. Votruba, M. Masojídková et al., “6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity,” Journal of Medicinal Chemistry, vol. 45, no. 9, pp. 1918–1929, 2002. View at Publisher · View at Google Scholar · View at Scopus
  193. D. Sriram, T. R. Bal, and P. Yogeeswari, “Aminopyimidinimo isatin analogues: design of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broadspectrum chemotherapeutic properties,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 3, pp. 565–577, 2005. View at Google Scholar · View at Scopus
  194. A. Mai, M. Artico, G. Sbardella et al., “5-alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives,” Journal of Medicinal Chemistry, vol. 42, no. 4, pp. 619–627, 1999. View at Publisher · View at Google Scholar · View at Scopus
  195. D. Hocková, A. Holý, M. Masojídková et al., “Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds,” Bioorganic and Medicinal Chemistry, vol. 12, no. 12, pp. 3197–3202, 2004. View at Publisher · View at Google Scholar · View at Scopus
  196. S. F. Mohamed, E. M. Flefel, A. E. E. Amr, and D. N. Abd El-Shafy, “Anti-HSV-1 activity and mechanism of action of some new synthesized substituted pyrimidine, thiopyrimidine and thiazolopyrimidine derivatives,” European Journal of Medicinal Chemistry, vol. 45, no. 4, pp. 1494–1501, 2010. View at Publisher · View at Google Scholar · View at Scopus
  197. M. B. Nawrozkij, D. Rotili, D. Tarantino et al., “5-alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones, a series of anti-HIV-1 agents of the dihydro-alkoxy-benzyl-oxopyrimidine family with peculiar structure-activity relationship profile,” Journal of Medicinal Chemistry, vol. 51, no. 15, pp. 4641–4652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  198. V. Summa, A. Petrocchi, V. G. Matassa et al., “HCV NS5b RNA-dependent RNA polymerase inhibitors: from α,γ-diketoacids to 4,5-dihydroxypyrimidine- or 3-methyl-5-hydroxypyrimidinonecarboxylic acids. Design and synthesis,” Journal of Medicinal Chemistry, vol. 47, no. 22, pp. 5336–5339, 2004. View at Publisher · View at Google Scholar · View at Scopus
  199. U. Koch, B. Attenni, S. Malancona et al., “2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: discovery, SAR, modeling, and mutagenesis,” Journal of Medicinal Chemistry, vol. 49, no. 5, pp. 1693–1705, 2006. View at Publisher · View at Google Scholar · View at Scopus
  200. F. Manetti, J. A. Esté, I. Clotet-Codina et al., “Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity,” Journal of Medicinal Chemistry, vol. 48, no. 25, pp. 8000–8008, 2005. View at Publisher · View at Google Scholar · View at Scopus
  201. S. Prekupec, D. Makuc, J. Plavec et al., “Novel C-6 fluorinated acyclic side chain pyrimidine derivatives: synthesis, 1H and 13C NMR conformational studies, and antiviral and cytostatic evaluations,” Journal of Medicinal Chemistry, vol. 50, no. 13, pp. 3037–3045, 2007. View at Publisher · View at Google Scholar · View at Scopus